STOCKHOLM, Feb. 4, 2020 /PRNewswire/ -- On February 11th, 2020, at 08:00 am (CET), Moberg Pharma AB (OMX: MOB) will
present its Interim report for July - December 2020. Investors, analysts and
journalists are hereby invited to participate in a teleconference
at 3:00 pm (CET) on the same
date.
The teleconference will be hosted by Moberg Pharmas's CEO
Anna Ljung and VP Finance
Mark Beveridge. The presentation
will be held in English.
Date: February 11th,
2020
Time: 3:00 pm (CET)
To participate in the conference, please dial in on any number
below before the start of the call:
SE: +46-8-505-583-69
US: +1-833-526-83-82
The quarterly report and other information material will be made
public on:
http://www.mobergpharma.com/investors/calendarpresentations
For additional information, please contact:
Anna Ljung, CEO, Phone: +
46-70-766-60-30, e-post: anna.ljung@mobergpharma.se
Mark Beveridge, VP Finance,
Phone: + 46-76-805-82-88, e-post:
mark.beveridge@mobergpharma.se
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/moberg-pharma/r/moberg-pharma-s-interim-report-to-be-published-on-february-11---invitation-to-teleconference,c3026328
The following files are available for download:
|
https://mb.cision.com/Main/1662/3026328/1187245.pdf
|
Moberg Pharma's
Interim report for July - December 2019 to be published on February
11 - Invitation to teleconference
|
View original
content:http://www.prnewswire.com/news-releases/moberg-pharmas-interim-report-to-be-published-on-february-11---invitation-to-teleconference-300998238.html
SOURCE Moberg Pharma